250
Participants
Start Date
April 1, 2024
Primary Completion Date
September 1, 2027
Study Completion Date
September 1, 2027
Placebo
Participants receive placebo (saline) intravenously. They will also have the opportunity to self-administer saline during the 60-minute free-access IV self-administration period in session 3.
Alcohol
Participants receive alcohol intravenously, clamped at BrACs of 20mg%, 40mg%, and 60mg%. They will also have the opportunity to self-administer alcohol (up to 120mg% BrAC) during the 60-minute free-access IV self-administration period in session 3.
RECRUITING
Ohio State University, Columbus
RECRUITING
Northeastern University, Boston
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Jessica Weafer
OTHER